Metabolic syndrome clusters and the risk of incident stroke: The atherosclerosis risk in communities (ARIC) study

Stroke

Volumn 40, Issue 1, 2009, Pages 200-205

  Rodriguez Colon, Sol M ^a   Mo, Jingping ^b   Duan, Yinkang ^a   Liu, Jiahao ^a   Caulfield, Joanne E ^a   Jin, Xuejuan ^a   Liao, Duanping ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Atherosclerosis; Cohort study; Metabolic syndrome; Stroke risk factors

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; BRAIN ARTERY; BRAIN ATHEROSCLEROSIS; CLUSTER ANALYSIS; COHORT ANALYSIS; COMORBIDITY; EPIDEMIOLOGY; HYPERGLYCEMIA; INCIDENCE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; STROKE;

CEREBRAL ARTERIES; CLUSTER ANALYSIS; COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; INTRACRANIAL ARTERIOSCLEROSIS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE;

EID: 60549107906     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.523035     Document Type: Article

References (37)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and Management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation. 2005;112:2735-2752.
4. International Diabetes federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/home/index.cfm?node = 1429. Accessed March 30, 2008.
5. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33: 351-375.
6. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am. 2004;33:333-350.
7. Flegal, KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes. 1998;22:39-47.
8. Ogden CL, Johnson CL, Carroll MD, Curtin LR, McDowell MA, Talak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
9. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update: a report from the Am Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113: e85-e151.
10. Silventoinen K, Sans S, Tolonen H, Monterde D, Kuulasmaa K, Kesteloot H, Tuomilehto J. WHO MONICA Project. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes. 2004;28:710-718.
11. Hong Y, Pedersen NL, Brismar K, de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet. 1997;60:143-152.
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
13. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the Am Heart Association and the Am College of Cardiology. Circulation. 1999;100: 1481-1492.
14. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. An update of the 1997 Am Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
15. Graham IM. Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol. 2005;20: 430-439.
16. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL; American Heart Association; American Stroke Association Stroke Council. Primary Prevention of Ischemic Stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;113:e873-e923.
17. ARIC investigators: The atherosclerosis risk in the communities (ARIC) study: Design and objectives. Am J Epidemiol. 1989;129:687-702.
18. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996;49:223-233.
19. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 1998;339:861-867.
20. Rosamond WD, Folsom AR, Chambless LE, Wang C, McGovern PG, Howard G, Cooper LS, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999;30:736-743.
21. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
22. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
23. Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ. HDL cholesterol quantitation by phosphotungstate-Mg2 + and by dextran sulfate-Mn2 +-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol. 1 982;78:718-723.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
25. Harris MM. Stevens J. Thomas N. Schreiner P. Folsom AR. Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study. Obes Research. 2000;8:516-524.
26. Schreiner PJ. Terry JG. Evans GW. Hinson WH. Crouse JR III, Heiss G. Sex-specific associations of magnetic resonance imaging-derived intraabdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1996;144:335-345.
27. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I: development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemos. 1989;61:15-19.
28. National Heart Lung and Blood Institute. ARIC manuals of operation: no. 1, general description and study management; no. 2, cohort component procedures; no. 3, surveillance component procedures; no. 4, pulmonary function assessment; no. 5, electrocardiography; no. 6, ultrasound assessment; no. 7, blood collection and processing; no. 8, lipid and lipoprotein determinations; no. 9, hemostasis determinations; no. 10, clinical chemistry determinations; no. 11, sitting blood pressure and postural changes in blood pressure and heart rate; no. 12, quality assurance. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.
29. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke. 2006;37:1060-1064.
30. Hong Y, Jin X, Mo J, Lin H-M, Duan Y, Pu M, Wolbrette DL, Liao D Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality - results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med. 2007;262: 113-122.
31. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
32. Bertoni AG, Wong ND, Shea S, Ma S, Liu K, Preethi S, Jacobs DR Jr, Wu C, Saad MF, Szklo M. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2007;30:2951-2956.
33. Clark LT, El-Atat F. Metabolic syndrome in African Americans: implications for preventing coronary heart disease. Clin Cardiol.2007;30: 161-164.
34. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, Paik MC. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke. 2008;39:30-35.
35. McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA Metabolic Syndrome and Cardiovascular Disease in Older People: The Cardiovascular Health Study. J Am Geriatrics Soc. 2006;54:1317-1324.
36. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 2007;6:13.
37. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics -2007 update: a report from the Am Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115;e69-e171.